CIK 0001533998
- Non-accelerated filer
- Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 452973162
- Phone
- +972 47706377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- 4 Open-market buy President and CCO bought 40,000 shares at $0.53 ($21,200)
- 4 Grant or award Chief Financial Officer acquired 500,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $0.91 ($4,546)
- 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.82 ($8,244)
- 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.82 ($12,292)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.88 ($4,400)
- 4 Open-market buy Chief Commercial Officer bought 15,000 shares at an average $0.94 ($14,147)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.94 ($9,400)
- 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.93 ($9,283)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.90 ($8,980)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 400,000 shares (grant or award)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 70,000 shares (grant or award)
Page 2 of 20 · 387 filings